Registry-listed formulations

Labetalol Hydrochloride · chembl:CHEMBL1200323

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

3 source entries across 3 studies. This list may not include all unresolved or historical entries.

Labetalol Hydrochloride 200 mgRegistry intervention
Linked study entry; product equivalence not established
View study and source
Trandate 5mg/ml Solution for InjectionRegistry product
Molecular identity unconfirmed
Formulation reported by source: SOLUTION FOR INJECTION
Named ingredient; exact form unconfirmed. This mention does not add to the molecule trial count.
View study and source
Labetalol Hydrochloride Oral TabletRegistry intervention
Molecular identity unconfirmed
View study and source

Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Not Applicable

33%

Early Phase 1

33%

Phase 4

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Early Phase 1First-in-human

1(33.3%)

Phase 4Post-market surveillance

1(33.3%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Other(1)

Detailed Status

Completed2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

Early Phase 11 (33.3%)

Phase 41 (33.3%)

N/A1 (33.3%)

Trials by Status

completed267%

unknown133%

Recent Activity

0 active trials

Showing 3 of 3

completedphase_4

Is Labetalol More Effective Than Metoprolol for Controlled Hypotensive Anesthesia During Endoscopic Nasal Surgeries?

NCT05368376

unknownearly_phase_1

Use of Impedance Cardiography to Decrease the Risk of Pre-eclampsia in Obese Patients

NCT03105661

completednot_applicable

Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage

NCT00226096

Clinical Trials (3)

Showing 3 of 3 trials

NCT05368376Phase 4

Is Labetalol More Effective Than Metoprolol for Controlled Hypotensive Anesthesia During Endoscopic Nasal Surgeries?

Completed

NCT03105661Early Phase 1

Use of Impedance Cardiography to Decrease the Risk of Pre-eclampsia in Obese Patients

Unknown

NCT00226096Not Applicable

Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage

Completed

All 3 trials loaded

Drug Details

Intervention Type: Drug
Molecule Type: Small molecule
Total Trials: 3

External References

ChEMBL

CHEMBL1200323

Names & Codes

Trade Names

trandate

Research Codes

AH 5158AAH-5158A HYDROCHLORIDENSC-290312SCH 15719WSCH-15719W HYDROCHLORIDE